POLISCOPE
Back to feed
FEDERALhearing transcript
High Impact

Congressional Hearing on Saccharin Ban Moratorium (1977)

Original title: Moratorium on saccharin ban: hearing before the Subcommittee on Health and the Environment of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-fifth Congress, first session on H.R. 7753 (and all identical bills) bills to direct the Institute of Medicine of the National Academy of Sciences to conduct a one-year review and evaluation of all available information respecting the toxicity and carcinogenicity of food additives, including information respecting the ability to predict the effect on humans of food additives found to cause cancer in animals and whether there should be a weighing of risks and benefits in making regulatory decisions respecting such additives, and to direct the Secretary of Health, Education, and Welfare to permit the continued use of Saccharin as a food, food additive, drug, and cosmetic for eighteen months, H.R. 8012 a bill respecting the continued use of saccharin as a food, food additive, drug, and cosmetic, and for other purposes, H.R. 5166 (and all identical bills) bills to amend the Federal Food, Drug, and Cosmetic Act to authorize an evaluation of the risks and benefits of certain food additives and to permit the marketing of saccharin until such an evaluation can be made it (and all other similar or identical bills) June 27, 1977.

July 20, 2026

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

The Frame

What this does

The hearing addresses whether the federal government should continue to allow the sale of saccharin in food and drugs while scientific studies on its potential cancer risks are evaluated.

Who is mentioned in the record

Potentially affected actors named in the source documents. Mention is not a position.

Food and Drug Manufacturers

These entities are affected by the legal status of saccharin as a permitted or banned additive in their products.

Consumers

Consumers are affected by the availability of products containing saccharin and the regulatory determination of its safety.

What changed

Last recorded activity July 20, 2026.

What's next

Next step not available in the current record.

Summary

This document is a transcript record of a 1977 House subcommittee hearing regarding proposed legislation to delay a government ban on the artificial sweetener saccharin. The bills under discussion aim to pause the ban for 18 months while the National Academy of Sciences conducts a comprehensive review of food additive safety and risk-benefit analysis.

Key Facts

  • The hearing was held on June 27, 1977, by the Subcommittee on Health and the Environment.
  • H.R. 7753 proposes an 18-month moratorium on the ban of saccharin as a food, drug, and cosmetic additive.
  • The legislation directs the Institute of Medicine to conduct a one-year review of the toxicity and carcinogenicity of food additives.
  • The review is tasked with determining if animal cancer studies can accurately predict human health effects.
  • The review is tasked with determining if regulatory decisions should weigh the risks and benefits of food additives.
  • H.R. 5166 proposes amending the Federal Food, Drug, and Cosmetic Act to authorize risk-benefit evaluations for food additives.
  • The bills seek to allow the continued marketing of saccharin until the scientific evaluation is completed.

Frequently Asked Questions

What is the purpose of these bills?
The bills aim to pause a government ban on saccharin for 18 months to allow time for a scientific review of its safety.
Who would conduct the safety review?
The Institute of Medicine of the National Academy of Sciences is proposed to conduct the one-year review.

Why It Matters

The hearing addresses whether the federal government should continue to allow the sale of saccharin in food and drugs while scientific studies on its potential cancer risks are evaluated.

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Sponsors

Discoveries

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.

policy shift90% confidence

Risk-Benefit Analysis Debate

The hearing highlights a pivotal moment in regulatory history where Congress considered mandating risk-benefit analysis for food additives rather than relying solely on toxicity findings.

Connected Entities

organizationSubcommittee on Health and the EnvironmentThe congressional body conducting the hearing.Map →
personSecretary of Health, Education, and WelfareThe official tasked with permitting continued saccharin use under the proposed bMap →
organizationCommittee on Interstate and Foreign CommerceThe parent committee overseeing the subcommittee.Map →
organizationInstitute of Medicine of the National Academy of SciencesProposed to conduct a one-year review of food additive toxicity.Map →

Sources

Open source document

www.govinfo.gov

Analysis Score

0–100
  • Significance85
    How much this matters to a regular citizen
  • Controversy75
    Intensity of disagreement among stakeholders
  • Entertainment20
    Compellingness for a non-policy-wonk reader
  • Buzz10
    Current news / social attention level

Publisher tools

Share or embed this record

POLISCOPE publisher tools

Share or embed this record